Plasma malondialdehyde and nitric oxide levels in age related macular degeneration.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 11734513.
- Also identified by PMC identifier 1723807.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate alteration of plasma malondialdehyde (MDA) and nitric oxide (NO) levels in patients with exudative age related macular degeneration (ARMD). Plasma nitrite plus nitrate concentrations as an index of plasma NO levels and plasma MDA level as a marker of lipid peroxidation were measured in patients with exudative ARMD and age and sex matched healthy subjects. Significantly higher MDA and lower NO levels were detected in plasma of patients with ARMD compared with their controls (p=0.01, p=0.001, respectively). The results may support involvement of oxidative damage and vascular theory in the pathogenesis of ARMD as part of the ageing process.
Medical subject headings
- Macular Degeneration
- Malondialdehyde
- Nitric Oxide